Protalix BioTherapeutics Inc (PLX)
1.25
+0.08
(+6.84%)
USD |
NYAM |
Nov 01, 16:00
1.245
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Max Drawdown (5Y): 94.35% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 94.35% |
| September 30, 2024 | 94.35% |
| August 31, 2024 | 94.35% |
| July 31, 2024 | 94.35% |
| June 30, 2024 | 94.35% |
| May 31, 2024 | 94.35% |
| April 30, 2024 | 94.35% |
| March 31, 2024 | 94.35% |
| February 29, 2024 | 94.35% |
| January 31, 2024 | 94.35% |
| December 31, 2023 | 94.35% |
| November 30, 2023 | 94.35% |
| October 31, 2023 | 94.35% |
| September 30, 2023 | 94.40% |
| August 31, 2023 | 94.40% |
| July 31, 2023 | 94.40% |
| June 30, 2023 | 94.40% |
| May 31, 2023 | 94.40% |
| April 30, 2023 | 94.40% |
| March 31, 2023 | 94.40% |
| February 28, 2023 | 94.40% |
| January 31, 2023 | 94.40% |
| December 31, 2022 | 94.40% |
| November 30, 2022 | 94.40% |
| October 31, 2022 | 94.40% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.40% |
| August 31, 2022 | 94.40% |
| July 31, 2022 | 94.40% |
| June 30, 2022 | 94.40% |
| May 31, 2022 | 94.40% |
| April 30, 2022 | 94.40% |
| March 31, 2022 | 94.40% |
| February 28, 2022 | 94.40% |
| January 31, 2022 | 94.40% |
| December 31, 2021 | 94.40% |
| November 30, 2021 | 94.40% |
| October 31, 2021 | 94.40% |
| September 30, 2021 | 96.04% |
| August 31, 2021 | 96.04% |
| July 31, 2021 | 96.04% |
| June 30, 2021 | 96.04% |
| May 31, 2021 | 96.04% |
| April 30, 2021 | 96.04% |
| March 31, 2021 | 96.04% |
| February 28, 2021 | 96.04% |
| January 31, 2021 | 96.04% |
| December 31, 2020 | 96.04% |
| November 30, 2020 | 96.04% |
| October 31, 2020 | 96.04% |
| September 30, 2020 | 96.04% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.35%
Minimum
Oct 2023
96.04%
Maximum
Nov 2019
95.02%
Average
94.40%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Aethlon Medical Inc | 99.76% |
| Predictive Oncology Inc | 99.94% |
| bluebird bio Inc | 99.05% |
| AIM ImmunoTech Inc | 99.61% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -22.96 |
| Beta (5Y) | 0.6749 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.30% |
| Historical Sharpe Ratio (5Y) | -0.2057 |
| Historical Sortino (5Y) | -0.3873 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.70% |